PCG
GILD icon

Private Capital Group’s Gilead Sciences GILD Stock Holding History

Private Capital Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$118K Sell
1,912
-388
-17% -$24K 0.09% 230
2022
Q1 		$137K Sell
2,300
-353
-13% -$22.6K 0.03% 322
2021
Q4 		$193K Sell
2,653
-137
-5% -$9.44K 0.04% 243
2021
Q3 		$195K Buy
2,790
+179
+7% +$12.6K 0.04% 241
2021
Q2 		$180K Sell
2,611
-246
-9% -$16.4K 0.04% 250
2021
Q1 		$185K Sell
2,857
-317
-10% -$20.4K 0.05% 237
2020
Q4 		$185K Sell
3,174
-544
-15% -$32.8K 0.03% 328
2020
Q3 		$235K Sell
3,718
-2,467
-40% -$171K 0.05% 245
2020
Q2 		$476K Sell
6,185
-338
-5% -$25.9K 0.1% 141
2020
Q1 		$488K Buy
6,523
+1,511
+30% +$104K 0.13% 121
2019
Q4 		$325K Sell
5,012
-4,002
-44% -$261K 0.07% 180
2019
Q3 		$571K Buy
9,014
+4,246
+89% +$278K 0.1% 126
2019
Q2 		$338K Sell
4,768
-3,828
-45% -$252K 0.08% 157
2019
Q1 		$559K Buy
8,596
+1,230
+17% +$81.8K 0.11% 127
2018
Q4 		$461K Sell
7,366
-789
-10% -$55.1K 0.1% 136
2018
Q3 		$630K Buy
8,155
+2,172
+36% +$164K 0.13% 121
2018
Q2 		$423K Buy
5,983
+150
+3% +$10.6K 0.09% 147
2018
Q1 		$440K Buy
5,833
+1,327
+29% +$105K 0.1% 143
2017
Q4 		$323 Buy
+4,506
New +$342K 0.08% 171

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Private Capital Group's GILD Position: Q2 2022 in Review

Private Capital Group reduced its Gilead Sciences (GILD) stake by 17% in Q2 2022, selling an estimated $24K and leaving 1,912 shares worth $118K. The position accounts for 0.09% of the portfolio, ranked #230.

Private Capital Group first reported a position in GILD in Q4 2017 and has held it in 19 quarters since. The position peaked at $630K in Q3 2018. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Private Capital Group held 1,912 shares of Gilead Sciences worth $118K as of Q2 2022.
  • Private Capital Group sold 388 Gilead Sciences shares in Q2 2022, an estimated $24K.
  • Gilead Sciences made up 0.09% of Private Capital Group's portfolio in Q2 2022, its #230 holding.
  • Private Capital Group first reported a position in Gilead Sciences in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Gilead Sciences position peaked at $630K in Q3 2018.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.